Khalid Mehmood MD

Chief Medical Officer (Global)

Dr. Khalid joined Byonyks, Inc. as a Cheif Medical Officer in September 2021. Dr. Khalid is a renowned Nephrologist (Kidney Specialist) with over 30 years of experience in caring for Patients with diverse Kidney Diseases and also patients who have Kidney Failure and require Dialysis.
He is a Serial Healthcare Entrepreneur with diversified experience as a Founder, President, Medical Director, and CEO of a Group Practice, Multiple Dialysis Clinics, a Home Health Agency, a Hospice, a Clinical Research Company, and an Acute Care Hospital with a Medical Staff of 175 Physicians. He is a passionate and visionary leader who strives to improve the lives of patients and communities through innovation, collaboration, and excellence.
Additionally, he holds the esteemed position of founding president at The Organization of Pakistani Entrepreneurs (OPEN) Dallas, a vibrant network comprising entrepreneurs and professionals dedicated to fostering leadership and driving social impact within the Dallas community. Leveraging his skills, expertise, and extensive experience, he actively contributes to raising funds for startups, as well as launching and scaling ventures. With an extensive network encompassing physicians, healthcare experts, and entrepreneurs from diverse sectors, he possesses the remarkable ability to connect with thousands of healthcare professionals, facilitating valuable collaborations and opportunities.

As a Chief Medical Officer at Byonyks, Dr. Khalid plays a pivotal role in directing the development and implementation of the Automated Peritoneal Dialysis (APD) Cycler, equipped with cutting-edge technology that promises to disrupt the Global Dialysis Market. This revolutionary advancement is poised to substantially decrease the escalating costs associated with dialysis. Byonyks’ groundbreaking bloodless dialysis cycler, along with other innovative solutions, has the potential to provide a life-saving alternative for countless individuals suffering from kidney failure, particularly in areas where access to the APD Cycler is currently limited.”